NCT Number: NCT00920010
S9925: Collecting and Storing Samples From Patients With Lung Cancer
RATIONALE: Collecting and storing samples of tissue, blood, and sputum from patients with cancer to study in the laboratory may help the study of cancer in the future.
PURPOSE: The purpose of this study is to collect and store tissue, blood, and sputum samples from patients with lung cancer to be tested in the laboratory.
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
All sexes
Study type
Observational
Primary location
Providence Cancer Center at Providence Hospital, Mobile, Alabama, United States
About this study
OBJECTIVES:
- Establish a central lung cancer specimen repository to serve as a resource for current and future scientific studies.
- Correlate clinicopathologic information in the Southwest Oncology Group clinical data base with results of studies using the repository.
- Test new hypotheses with the specimens in the repository.
OUTLINE: Peripheral blood, sputum, and biopsy specimens are collected from patients. Tissue samples are frozen and stored in a lung cancer specimen repository for later use in correlative studies.
PROJECTED ACCRUAL: Not specified
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS:
- Enrolled on one of the following Southwest Oncology Group protocols:
- SWOG-8805, SWOG-9019, SWOG-9416, SWOG-9509, SWOG-S9900, SWOG-S0003, SWOG-S0023, SWOG-S0126, SWOG-S0435, SWOG-S0220, SWOG-S0222, SWOG-S0327, SWOG-S0310, SWOG-S0339, SWOG-S0342, SWOG-S0341, SWOG-S0509, SWOG-S0429, or SWOG-S0124
PATIENT CHARACTERISTICS: Not specified
PRIOR CONCURRENT THERAPY: Not specified
Treatment and study plan
Primary outcomes
-
Establishment of a central lung cancer specimen repository to serve as a resource for current and future scientific studies
Time frame: From date of study activation to consolidation of specimen banks
-
Correlation of clinicopathologic information in the Southwest Oncology Group clinical data base with results of studies using the repository
Time frame: From date of study activation to consolidation of specimen banks
-
Test of new hypotheses with the specimens in the repository
Time frame: From date of study activation to consolidation of specimen banks
Sponsors and collaborators
Lead sponsor
SWOG Cancer Research Network
Network
Collaborators
- National Cancer Institute (NCI)
Registry information
Official study title
Lung Cancer Specimen Repository Protocol, Ancillary
Important dates
- Study start
- 2000
- Primary completion
- 2013
- Study completion
- 2013
- First posted
- Jun 12, 2009
- Registry last updated
- Feb 6, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Trial of NanoPac Intratumoral Injection in Lung Cancer
NCT04314895
Bronchial Neoplasms, Carcinoma, Bronchogenic
Gainesville, Florida, United States
View Trial DetailsA Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer
NCT02922764
Bronchial Neoplasms, Carcinoma, Bronchogenic
Tucson, Arizona, United States
View Trial DetailsA Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China
NCT05337163
Actinomycetales Infections, Acute Bronchitis
Guangzhou, Guangdong, China
View Trial DetailsReveal the Patterns of Presentation, Management and Outcome of Patients With SCLC and Stage III NSCLC in Saudi Arabia:
NCT04836975
Bronchial Neoplasms, Carcinoma, Bronchogenic
Riyadh, Saudi Arabia
View Trial Details